| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.001 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |